All Stories

  1. New therapies for highly sensitized patients on the waiting list

    Article • Kidney360, July 2024, Wolters Kluwer Health

    Dr Ashley A Vo

  2. Prognostic tools to assess candidacy for and efficacy of antibody-removal therapy

    Article • American Journal of Transplantation, August 2018, Wiley

    Dr Ashley A Vo, Anat Tambur

  3. A phase I/II, double-blind, placebo-controlled study assessing safety and efficacy of C1 esterase inhibitor for prevention of delayed graft function in deceased donor kidney transplant recipients

    Article • American Journal of Transplantation, May 2018, Wiley

    Dr Ashley A Vo

  4. Risk factors for the development of antibody-mediated rejection in highly sensitized pediatric kidney transplant recipients

    Article • Pediatric Transplantation, September 2017, Wiley

    Dr Ashley A Vo

  5. Benefits, efficacy, cost-effectiveness and infectious complications in transplant patients desensitized with intravenous immunoglobulin and anti-CD20 therapy

    Article • Clinical & Experimental Immunology, December 2014, Wiley

    Dr Ashley A Vo

  6. Transplantation in highly HLA-sensitized patients: challenges and solutions

    Article • Transplant Research and Risk Management, September 2014, Taylor & Francis

    Dr Ashley A Vo

  7. Infectious Complications in Kidney-Transplant Recipients Desensitized with Rituximab and Intravenous Immunoglobulin

    Article • Clinical Journal of the American Society of Nephrology, December 2011, American Society of Nephrology

    Dr Ashley A Vo, Project Scientist Shili Ge